The cellular magnetic response and biocompatibility of biogenic zinc- and cobalt-doped magnetite nanoparticles. by Moise, S et al.
1Scientific RepoRts | 7:39922 | DOI: 10.1038/srep39922
www.nature.com/scientificreports
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Neil D. Telling2
The magnetic moment and anisotropy of magnetite nanoparticles can be optimised by doping with 
transition metal cations, enabling their properties to be tuned for different biomedical applications. 
In this study, we assessed the suitability of bacterially synthesized zinc- and cobalt-doped magnetite 
nanoparticles for biomedical applications. To do this we measured cellular viability and activity in 
primary human bone marrow-derived mesenchymal stem cells and human osteosarcoma-derived 
cells. Using AC susceptibility we studied doping induced changes in the magnetic response of the 
nanoparticles both as stable aqueous suspensions and when associated with cells. Our findings show 
that the magnetic response of the particles was altered after cellular interaction with a reduction in 
their mobility. In particular, the strongest AC susceptibility signal measured in vitro was from cells 
containing high-moment zinc-doped particles, whilst no signal was observed in cells containing the 
high-anisotropy cobalt-doped particles. For both particle types we found that the moderate dopant 
levels required for optimum magnetic properties did not alter their cytotoxicity or affect osteogenic 
differentiation of the stem cells. Thus, despite the known cytotoxicity of cobalt and zinc ions, these 
results suggest that iron oxide nanoparticles can be doped to sufficiently tailor their magnetic 
properties without compromising cellular biocompatibility.
The ability of magnetic nanoparticles (MNPs) to transduce external magnetic field energy into a mechanical or 
thermal response can be exploited for biomedical applications, with research focussed on developing particles 
tailored to suit specific applications1–7. These particles’ magnetic response to an external magnetic field depends 
on properties such as their size, core composition and surface coating. Modifying their composition by doping 
transition metal cations into the iron oxides cores alters the nanoparticles’ magnetic moments8,9 and magnetic 
anisotropies10–12. By altering these two key properties the response of the nanoparticles to an external magnetic 
field can be defined. For instance, modifying the magnetic moment of the nanoparticles affects their efficiency as 
contrast agents in magnetic resonance imaging (MRI), whilst their magnetic anisotropy determines whether they 
are in a superparamagnetic state at physiological temperature (37 °C). In addition, both these properties affect the 
heating power of MNPs when exposed to high-frequency oscillating magnetic fields such as those used in mag-
netic hyperthermia13–17. This effect is currently being explored as a potential cancer therapy by using nanoparti-
cles to deliver sufficient heating to trigger heat shock-associated cancer cell death2,3,18. Other applications utilising 
this heating property include heat-activated drug release using thermosensitive polymer coated nanoparticle 
carriers4,19, thermal imaging of target tissue5 and thermal activation of cell membrane ion channels20.
We have previously explored a bacterial synthesis route to obtain controlled biogenic preparation of magnet-
ite nanoparticles, including those doped with either zinc or cobalt cations21–24. Analysis of these particles shows 
that they have a high degree of crystalline site ordering of the dopant cations25, leading to dramatic enhance-
ments in either anisotropy in the case of cobalt dopants23,24 or magnetic moment for zinc-doped particles21. 
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We have also assessed the magnetisation relaxation effects and heating properties of these doped particles, with 
relevance to magnetic hyperthermia applications, and found differences in heating efficiencies between zinc- and 
cobalt-doped particles that depend on their degree of mobility26. However before these properties can be further 
utilised in biological environments it is necessary to assess the effect of the introduction of transition metal ions 
on the biocompatibility of the iron oxide core.
Nanoparticles, when endocytically internalized by cells, are localized in lysosomes the highly acidic nature of 
which may corrode the core, releasing metal ions within the cell27,28. This is toxic to cells as metals such as zinc and 
cobalt, in their ionic form, are known cytotoxic agents29–32. Previous studies have shown evidence of cytotoxicity 
for chemically synthesized doped magnetite nanoparticles, indicating that doping modifies the biocompatibility 
of the nanoparticles9,33,34. Also, it is important to assess the effect doped MNPs have on normal cellular activities 
such as the ability of stem cells to differentiate along various lineages6,35–37, an important property being exploited 
in regenerative medicine therapies38–41.
In this work we assessed the suitability of doped magnetite nanoparticles for cellular applications, considering 
particles of the form MxFe3−xO4, where M = Co (x = 0.4, 0.7, 1) or Zn (x = 0.4, 0.6, 0.9), obtained using the iron 
(III) reducing bacteria Geobacter sulfurreducens21–24. For comparison, we also examined undoped (zero cobalt or 
zinc doping) magnetite nanoparticles produced both biogenically and by traditional chemical synthesis (com-
mercially available).
We explored the effect of nanoparticle association on two different cell types: primary human bone marrow 
derived mesenchymal stem cells (hMSCs), and human osteosarcoma derived cells (MG-63s). hMSCs are multipo-
tent stem cells which have shown promise in treating connective tissue injuries42 such as osteoarthritis and vari-
ous types of bone fractures. MNPs have been used in stem cell based therapies to trigger osteogenic differentiation 
as well as for stem cell tracking in vivo. Hence hMSCs are good candidates for evaluating the suitability of the 
doped MNPs for cellular applications. The MG-63s were also used as they mimic the bone precursor cell pheno-
type. Being a cancerous cell line, the comparison would help assess any associated changes in cytotoxic sensitivity 
to nanoparticles43 and give a better understanding of the doped MNPs interaction with different cells types.
As the changes in physiochemical conditions in a cellular environment could also affect the magnetic response 
of the nanoparticles44–46, we measured the AC susceptibility (ACS) of the MNPs47,48 to directly determine this 
response for doped biogenic and undoped chemically synthesized (synthetic) MNPs, both in free suspension and 
following cellular interaction.
ACS determines how the MNPs respond to an oscillatory (i.e. AC) magnetic field. When exposed to such a 
field the particles initially tend to partially align with the field direction. However, this magnetisation alignment 
can subsequently be relaxed either due to physical rotation of the particles caused by collisions with molecules in 
the suspending fluid (so called Brownian relaxation), or by the thermally induced reorientation of the internal 
particle magnetic spins (Neél relaxation). The shorter mode of relaxation is the more dominant one and this 
depends on various factors. For example the magnetic anisotropy and size of the MNP cores affect the Neél relax-
ation time, whilst environmental factors such as the viscosity of the solvent and temperature as well as the size of 
the MNP clusters (hydrodynamic size) affect the Brownian relaxation time. ACS is a complex quantity measured 
as a function of the frequency of the oscillating field, and is thus resolved into a real (χ’) and an imaginary (χ”) 
component. Whilst both components reflect the relaxation mechanisms that occur, a peak in the χ” component 
at a given frequency reveals the relaxation time for the particles. Generally, lower frequencies of the applied field 
match the Brownian relaxation times for particles which cannot rotate their internal magnetic spins (so called 
magnetically blocked particles). On the other hand, MNPs with small magnetic core sizes have shorter Neél relax-
ation times that match with higher field frequencies.
We have shown previously that ACS is an effective technique to non-invasively probe the magnetic response 
of nanoparticles in live cells26,49. In this study, we measured the ACS signal in cells associated with either zinc 
or cobalt-doped biogenic nanoparticles, as well as undoped nanoparticles. Further to this, we determined the 
cytotoxicity of these particles using differential live/dead cell staining, quantified by flow cytometry. Additionally, 
we studied the effect of cellular association with the nanoparticles on the osteogenic differentiation potential of 
hMSCs.
Results
Effect of cells on nanoparticles’ magnetic behaviour. Both zinc and cobalt doped biogenic MNP types 
have been thoroughly characterized by different techniques such as inductively coupled plasma analysis (ICP), 
X-ray diffraction (XRD), transmission electron microscopy (TEM) and X-ray absorption spectroscopy (XAS) as 
reported previously21,24. With doping, the core diameter of the nanoparticle decreases with increasing levels of 
cobalt or zinc as shown in Table 1. Core sizes are smaller than 15 nm with an average polydispersity of 0.3 for all 
the biogenic samples and are 24 nm for the synthetic magnetite sample49. The hydrodynamic diameter (cluster 
size) following citric acid coating of the nanoparticles are also shown. The sizes were calculated from ACS meas-
urements for the nanoparticles in water using equation (1). The ACS technique has the advantage of measuring 
the hydrodynamic size of the particles based purely on their magnetic behaviour without interference by other 
non-magnetic26,47 material not associated with the nanoparticle and hence was preferred over the DLS technique 
when possible. However, due to the very weak magnetism of CoFe2O424 and Zn0.9Fe2.1O421, their hydrodynamic 
sizes cannot be measured via ACS and were hence obtained from dynamic light scattering (DLS) measurements. 
The sizes of the particle clusters range from 30–65 nm for most nanoparticles but are slightly larger (~85 nm) for 
the highest cobalt or zinc doping. However it should be noted that the final hydrodynamic size of the nanoparti-
cle clusters is likely to be larger than the values given in Table 1, due to the effects of additional clustering in cell 
culture media and protein corona formation49,50.
The ACS measurements for 100 μ M solutions of synthetic Fe3O4, biogenic Zn0.4Fe2.6O4 and Co0.4Fe2.6O4 nan-
oparticles are compared in water and when incubated with cells (for 72 h) in Fig. 1. The peaks in the χ” curves 
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seen for the aqueous suspensions of the three different MNP types (Fig. 1a–c) are typical of a Brownian magne-
tisation relaxation process, with the frequency position of this peak depending on the hydrodynamic size of the 
particles26. Although the nanoparticle core sizes vary between samples depending on the level of doping21,24, the 
similar positions of these χ ” peaks in the ACS curves reveal comparable hydrodynamic particle/cluster sizes for 
all particle types (40–65 nm) (Table 1).
The χ’ curves unlike the χ” curves show distinct variations in their relative shapes for the different particle 
types in water (Fig. 1a–c). For example, the cobalt-doped nanoparticles in water, show a symmetrical χ” peak at 
around 10 kHz (Fig. 1c) and a complete loss in the χ’ signal beyond this value. This indicates a single dominat-
ing mode of relaxation which is expected to be Brownian relaxation for the magnetically blocked cobalt MNPs 
due to their high anisotropy24,26. In contrast, both undoped synthetic magnetite and zinc-doped nanoparticles 
have an asymmetrical χ” peak with the real (χ’) component greater than zero at higher frequencies. This can be 
explained by the presence of a fraction of nanoparticles with small core size, due to the polydisperse nature of the 
suspensions, exhibiting superparamagnetic properties and relaxing via the Neél relaxation mode to contribute to 
the ACS signal26.
In cells, the magnitude of AC susceptibility is reduced by a factor of ~20 for synthetic Fe3O4 (Fig. 1d) com-
pared to a factor of ~10 for Zn0.4Fe2.6O4 (Fig. 1e). Most dramatically, the cobalt-doped MNPs, which showed the 
strongest signal in water, give a negligible response in cells with almost zero susceptibility signal (Fig. 1f). Further 
to this the peaks in the χ” component, associated with Brownian relaxation, are absent for all the particle types 
when in cells (Fig. 1d–f). These results are entirely consistent with the complete removal of the Brownian relax-
ation from the ACS signal such that only the weaker contribution from the MNPs relaxing via the Neél mode 
remains26.
Effect of nanoparticles on cell viability. To further investigate the cellular interaction with the MNPs, 
we obtained fluorescent micrographs of human osteosarcoma MG-63 cell line (Fig. 2) and the primary hMSCs 
(Fig. 3) following treatment. The cells were incubated either with MNPs, or the equivalent concentration of 
known cytotoxic agent CoCl229,30,32 salt to assess the relative cytotoxicity of the MNPs. This was achieved by 
using equivalent cation concentrations for CoCl2 and the MNPs, namely Co2+ for the salt and Co2+ + Fe2+ or 
Zn2+ + Fe2+ for the nanoparticles. These nanoparticles have already been shown to be internalized following 48 h 
incubation with MG-63 cells49.
In the case of the MG-63 cells, a large live population (stained green; Fig. 2a–c) and a correspondingly lower 
compromised population (stained red; Fig. 2e–g) is observed following exposure to synthetic Fe3O4 and the high-
est cobalt-doped MNP, CoFe2O4. Similarly, hMSCs exposed to synthetic Fe3O4, and biogenic Zn0.4Fe2.6O4 and 
Co0.4Fe2.6O4 have a large viable population (Fig. 3a–d) with minimal number of compromised cells (Fig. 3f–i). 
In contrast, a very large compromised population is observed for both cell types, when exposed to equivalent 
amounts of the ionic form of Co2+ as CoCl2 (Fig. 2d,h for MG-63s and Fig. 3e,j for hMSCs). These qualitative 
visual observations were backed up by quantitative flow cytometry to determine the percentage of cell popula-
tions staining for Calcein (live cells) and EthD (compromised cells), as shown in Fig. 4.
The effect of increasing the concentration of CoFe2O4 from 10 to 500 μ M MNP concentration on MG-63 
cells is compared to equivalent amounts of synthetic Fe3O4 and CoCl2 in Fig. 4a. Within the concentration range 
investigated, synthetic Fe3O4 is comparable to the no-nanoparticle control at all MNP concentrations with a ~95% 
live and ~5% compromised population. CoFe2O4 is also comparable to the no-nanoparticle control and syn-
thetic magnetite, except at the highest concentration tested (500 μ M). At this concentration of CoFe2O4, a minor 
increase in the compromised population is observed from 5% to ~10%. On the other hand, the CoCl2 treated cells 
show a dose dependant fall in the live population and a concomitant increase in the compromised population of 
up to 33% at 250 μ M and an even higher loss of almost 98% at 500 μ M Co2+ concentration.
The effect of the level of doping for cobalt and zinc was assessed in MG-63 cells at a fixed 500 μ M MNP con-
centration, as shown in Fig. 4b. This high concentration was chosen as it is well above that required for applica-
tions, with significant cytotoxicity found for cells treated with the CoCl2 salt. The undoped synthetic and biogenic 
Fe3O4 MNPs had comparable biocompatibility to the nanoparticle-free control of almost 94% live population. 
For both zinc- and cobalt-doped MNPs, cytotoxicity increased in line with the level of doping, with the live pop-
ulation at 93% for Co0.4Fe2.6O4, decreasing to 80% for Co0.7Fe2.3O4 and 74% for the highest cobalt doped sample 
Particle type
Core diameter 
(nm)
Hydrodynamic 
diameter (nm)
Synthetic Fe3O4 24 48
Biogenic Fe3O4 16 37
Co0.4Fe2.6O4 13 42
Co0.7Fe2.3O4 8 34
CoFeO4 2–4 84
Zn0.4Fe2.6O4 11 64
Zn0.6Fe2.4O4 11 37
Zn0.9Fe2.1O4 8 87
Table 1.  Core and hydrodynamic sizes of the nanoparticles: Core sizes as measured via TEM21,24 
and hydrodynamic sizes of aqueous suspensions of citric acid-coated MNPs as calculated from ACS 
measurements or in the case of CoFe2O4 and Zn0.9Fe2.1O4 from DLS measurements.
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of CoFe2O4. For zinc doping, the cytotoxic effect was more marked with an almost 98% compromised population 
for the highest zinc-doped MNP (Zn0.9Fe2.1O4). For the lower levels of zinc doping, namely Zn0.4Fe2.6O4 and 
Zn0.6Fe2.4O4 have a minor decrease in viability with a 93% live population for both particle types. As expected, 
the MG-63 cells treated with the equivalent CoCl2 concentration, showed almost 100% loss in viability (~100% 
compromised cells).
We found that hMSCs were more sensitive to the addition of cytotoxic agents, with a ~70% compromised 
population when treated with only 100 μ M CoCl2 (Fig. 4c). For this reason, to make comparative cytotoxic meas-
urements using MNPs, the hMSCs were also treated with 100 μ M concentrations of synthetic and doped biogenic 
MNPs (Fig. 4c), setting cobalt and zinc doping levels consistent with those required to induce the enhanced 
magnetic properties discussed earlier. In these cases the cellular viability at 100 μ M of synthetic magnetite, 
Figure 1. AC volumetric susceptibility curves of stable aqueous suspensions of nanoparticles and in cells: 
Measurements for synthetic Fe3O4 (a), Zn0.4Fe2.6O4 (b), and Co0.4Fe2.6O4 (c) in water and synthetic Fe3O4 (d), 
Zn0.4Fe2.6O4 (e), and Co0.4Fe2.6O4 (f) when associated with MG-63 cells following 72 hours incubation. [Data 
limited to lower frequencies in the more dilute samples (d–f)].
Figure 2. Cytotoxicity of 500 μM MNPs following 72 hours incubation with the human osteosarcoma 
cell line (MG-63s): Fluorescent micrographs of viable cells stained for Calcein (top) and compromised 
cells’ nuclei stained for ethidium homodimer (bottom). Cells not exposed to nanoparticles (a,e), exposed to 
synthetic Fe3O4 (b,f), CoFe2O4 (c,g) and CoCl2 (d,h) (scale bar 200 μ m).
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Co0.4Fe2.6O4 and Zn0.4Fe2.6O4 was at 99% live population and comparable to the untreated population, showing 
negligible evidence of a cytotoxic response (Fig. 4c).
Following cytotoxicity studies, the doped MNPs were assessed for possible effects on the differentiation poten-
tial of hMSCs. The osteogenic differentiation of hMSCs as measured via the alkaline phosphatase (ALP) assay51 at 
day 7 and 14 is shown in Fig. 5. Compared to the cells cultured in expansion media, cells cultured in osteogenic 
differentiation media show a significant up-regulation in the ALP production at day 7 and day 1452. However the 
ALP production of cells following internalization of synthetic Fe3O4, Zn0.4Fe2.6O4 and Co0.4Fe2.6O4, in osteogenic 
differentiation media, is not significantly different from the control cells in the same media (Fig. 5).
Discussion
In this study we explored the effect of interactions of cells and nanoparticles on the behaviour of each other. By 
comparing undoped, zinc and cobalt-doped iron oxide nanoparticles with differing magnetic properties we were 
able to highlight the changes in magnetic behaviour, especially in terms of the relaxation mechanisms when the 
MNP’s were associated with cells. The AC susceptibility measurements showed that the Brownian relaxation 
component observed for all the nanoparticle types when as aqueous suspensions was lost when they were asso-
ciated with cells. This could be due to immobilization of the nanoparticles when in cells which in turn could be 
because the nanoparticles were bound to the plasma membrane or intracellular membranes of cells. This result 
matches with the findings in the study by Hilger et al.53, where magnetorelaxometry measurements confirmed 
presence of MNPs relaxing via the Néel mode immobilized in cells. On the other hand, they did not study the 
effect on the Brownian relaxation mode of the MNPs. Another possible explanation for the loss in the Brownian 
mode of relaxation could be the aggregation of the nanoparticles upon internalization. The larger clusters could 
have sizes greater than that detectable by our ACS instrument’s frequency range (the maximum hydrodynamic 
size detectable in water is ~350 nm).
The relatively strong ACS signal from the zinc-doped nanoparticles in cells, compared to the cobalt-doped 
particles, has implications for intracellular magnetic heating applications that exploit magnetisation relaxation 
mechanisms. Previously we found that the comparatively strong magnetic hyperthermia effect measured in aque-
ous suspensions prepared from similar cobalt-doped nanoparticles, was suppressed following their immobilisa-
tion in glycerol26. A similar loss of the Brownian component when MNPs are associated with cells implies their 
heating efficiency will be suppressed unless strong magnetic field amplitudes are applied. Conversely the survival 
of Néel relaxation for the zinc-doped nanoparticles associated with cells, suggests cellular based magnetic hyper-
thermia might be possible with these particles even under clinically relevant magnetic field conditions.
Apart from the effect cells have on the magnetic behaviour of nanoparticles, the nanoparticles in turn could 
affect cellular functioning. Especially with the introduction of zinc and cobalt, changes in cytotoxicity could 
occur due to leaching of the metal ions from the nanoparticle core. By comparing to equivalent levels of free 
Co2+ ions, we find that the nanoparticles have lower levels of toxicity for the same cation concentrations. While 
the CoCl2 salt forms Co2+ ions in solution quite rapidly and will have an immediate effect on cell viability, the 
citric acid surface coating of the magnetic nanoparticles delays leaching of the metal core and hence release of 
toxic ions into solution. Indeed, uncoated ~30 nm cobalt nanoparticles at concentrations as low as 2 μ M have 
previously been shown to significantly reduce the viability of human fibroblasts within 72 h of exposure27. In 
addition, the cations are tightly bound within a magnetic lattice21,23,24 which reduces release of the metal ions 
into solution. With time, when the nanoparticles are internalized by cells, they are stored within lysosomes6 the 
acidic environments of which could cause leaching of the surface coating and subsequent release of the core metal 
Figure 3. Cytotoxicity of 100 μM MNPs following 72 hours incubation on hMSCs: Fluorescent 
micrographs of viable cells stained for Calcein (top) and compromised cells’ nuclei stained for ethidium 
homodimer (bottom). Cells not exposed to nanoparticle (a,f), cells exposed to synthetic magnetite (b,g), 
Zn0.4Fe2.6O4 (c,h) Co0.4Fe2.6O4 (d,i) and CoCl2 (e,j) (scale bar 100 μ m).
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ions. This could explain the increase in cytotoxicity with increasing level of doping observed in our study. This 
effect was also observed in another study54 evaluating the cytotoxicity of chemically synthesized zinc-doped iron 
oxide nanoparticles. A dose dependant decrease in mitochondrial metabolic activity (as measured via MTT) and 
increase in membrane damage (as measured via the LDH assay) was observed in human lung epithelial (A549), 
skin epithelial (A431) and liver (HepG2) cells. An almost 60% reduction in the mitochondrial metabolic activity 
Figure 4. Cytotoxicity of MNPs following 72 hour incubation using flow cytometry quantification of live/
dead staining: MNP incubation with human osteosarcoma (MG-63) cells using (a) varying concentrations of 
synthetic Fe3O4 (synFe3O4) and CoFe2O4 (Co1.0), and (b) 500 μ M concentrations with varying dopant levels 
of Cobalt (0.4, 0.7, 1) and Zinc (0.4, 0.6, 0.9). (c) Cytotoxicity of Zn0.4Fe2.6O4 (Zn0.4) and Co0.4Fe2.6O4 (Co0.4) 
at 100 μ M MNP concentrations in hMSCs. In all cases, the cytotoxic effect of equivalent concentrations of the 
Co2+ ion in its salt form (CoCl2) was compared to the metal nanoparticles. Columns represent the mean for 
n = 3 and the error bars the standard error of the mean. No error bars displayed for the following samples: (a) 
250 μ m, 500 μ m CoCl2; (b) Zn0.9, CoCl2; (c) CoCl2.
www.nature.com/scientificreports/
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and ~60% increase in membrane damage was observed for all three cell types following 24 h exposure to 40 μ g/ml 
of the uncoated MNPs.
Another parameter that has been shown to affect nanoparticle cytotoxicity is their size. A study on uncoated 
silver nanoparticles showed that cytotoxicity increased with decrease in the core size of the nanoparticles55 from 
> 100 nm to 20 nm. This is attributed to their large surface-to volume ratio resulting in faster dissolution of the 
core with higher rate of ion release56 thereby affecting cell viability. In the nanoparticles that we investigated, 
increasing levels of doping causes a corresponding decrease in core sizes. The increase in cytotoxicity of the 
nanoparticles with increase in level of doping observed in this study could be a combined contribution of the 
increasing levels of dopant and the decrease in the nanoparticle core size.
When comparing the cytotoxicity of the doped MNPs, a more pronounced increase in cytotoxicity with level 
of doping was found with zinc than cobalt which shows a similar but much more gradual trend. The highest 
zinc-doped MNP (Zn0.9Fe2.1O4) heavily affects cellular viability (with an almost 99% compromised population). 
One possible explanation for this could be because zinc ions are more cytotoxic than cobalt ions31. However, 
another possible explanation could be the interaction of the zinc with the citrate surface coating. It is known that 
the solubility of zinc oxide is enhanced in the presence of citrate and that it depends on the core nanoparticle 
size irrespective of the cluster (hydrodynamic) sizes57. This, together with the higher levels of zinc doping, would 
explain the enhanced toxicity as the Zn0.9Fe2.1O4 MNPs which have smaller core sizes and hence higher surface 
area in comparison to the lower doped zinc nanoparticles21,24. On the other hand, cobalt oxide solubility is not 
significantly affected by presence of citrate58 and hence a gradual and minor increase in cytotoxicity is observed 
with increasing levels of cobalt doping.
Apart from cell viability the differentiation behaviour of stem cells was also investigated in this study. The oste-
ogenic differentiation of the mesenchymal stem cells was found to be unaffected by their uptake of the zinc and 
cobalt-doped nanoparticles as measured via the ALP marker expression. More generally, the effect of magnetic 
nanoparticles on the trilineage differentiation of stem cells seems to depend on the particle type and the lineage of 
differentiation. For instance while chitosan-coated superparamagnetic iron oxide particles did not interfere with 
osteo-/adipo-/ chondrogenic differentiation of bone marrow derived hMSCs59, clinically approved MRI contrast 
agent nanoparticle Resovist/Ferucarbotran was shown to affect differentiation60,61. While one study shows that 
Resovist particles inhibit only the chondrogenic differentiation60 (not adipo- or osteogenic) another study61 shows 
that the same nanoparticle does inhibit osteogenic differentiation in the same cell type. Such contradicting results 
increase the need to thoroughly assess effects of all different nanoparticles on stem cell behaviour. Further studies 
are needed to ensure that the zinc- and cobalt-doped nanoparticles used in this study do not affect the minerali-
zation, adipogenic and chondrogenic potential of hMSCs. The results obtained here identify the potential of these 
biogenic doped magnetite nanoparticles for cellular applications.
In conclusion, our results show that biogenic nanoparticles with moderate levels of cobalt and zinc dop-
ing, with optimised magnetic properties for cellular applications, have minimal short term acute cytotoxicity 
within concentrations suitable for cellular applications. In addition preliminary studies show that they that do not 
interfere with osteogenic differentiation. The assessment of their magnetic behaviour when associated with cells 
shows a diminished magnetic response depending on the particle type, indicative of reduced particle mobility. 
Particularly, a strong Néel magnetisation relaxation mechanism is preserved in zinc-doped iron oxide nanopar-
ticles which is suitable for applying localised and controlled heating effects in cellular hyperthermia. However 
further studies monitoring the longer term toxicity and fate in vivo are needed to assess the full clinical potential 
of these particles.
Figure 5. Effect of MNPs on the osteogenic differentiation potential of hMSCs: hMSCs were exposed to 
100 μM of synthetic Fe3O4 (syn Fe3O4), Zn0.4Fe2.6O4 (Zn0.4) and Co0.4Fe2.6O4 (Co0.4) for 72 hours following 
which they were incubated in osteogenic (OST) media. Osteogenesis was measured through ALP production 
and normalized to cell number by measuring DNA content at day 7 and 14. ALP production was compared 
to cells not exposed to nanoparticles grown in expansion media (No MNP EXP) and osteogenic media (No 
MNP OST). Columns represent the mean for n = 3 and the error bars the standard error of the mean. Line over 
columns indicates groups that were not significantly different from each other (Tukey’s HSD, p < 0.05).
www.nature.com/scientificreports/
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Methods
Magnetic nanoparticle suspensions. Chemically synthesized magnetite (referred to as synthetic mag-
netite) was obtained from Sigma- Aldrich, UK. The biogenic nanoparticles were produced via microbial iron 
reduction of zinc and cobalt-doped ferrihydrite by the iron reducing bacteria Geobacter sulfurreducens according 
to the methods described previously21,24.
Stable aqueous suspensions of nanoparticles were prepared by citric acid coating using procedures described 
in detail elsewhere13,24. The suspensions were sterilized using 0.2 μ m filters prior to use in cellular experiments. 
Nanoparticle suspension concentrations were measured using the Ferrozine method for iron following complete 
digestion by concentrated nitric acid (70%) at high temperatures (> 60 °C) overnight.
Nanoparticle sizes were characterized using dynamic light scattering (DLS) measurements as aqueous suspen-
sions in a Zetasizer 3000 (Malvern, UK) instrument.
Cell culture. MG-63, an osteosarcoma cell line (Lonza, UK) and human bone marrow derived primary mes-
enchymal stem cells (less than 5 passages) (Lonza, UK) were seeded in expansion media consisting of 4.5 gL−1 
glucose Dulbecco’s Modified Eagle’s medium (Lonza, UK) supplemented with 10% foetal bovine serum, 1% 
Penicillin/Streptomycin (antibiotics and antimycotics) and 1% L-glutamine in well plates at ~80% confluency 
and allowed to attach overnight before addition of nanoparticle suspensions. hMSCs were adherence selected 
and tested for stemness using standard trilineage differentiation and flow cytometry for CD markers. Aqueous 
suspensions of the nanoparticles were mixed with cell culture media at 10% v/v and then added to cells. For the 
control samples, equivalent amount of sterile distilled water (negative control) or sterile cobalt chloride solution 
(positive control; Sigma- Aldrich, UK) at a concentration of 500 μ M were mixed with the cell culture media and 
added to cells. The cation/MNP concentrations were maintained constant between comparisons and cells were 
incubated with the additives for 72 h before being assessed.
AC Magnetic Susceptibility. The AC magnetic susceptibility was measured in a custom built AC suscep-
tometer on 200 μ l of the sample contained in a glass vial. The oscillating magnetic field frequency was swept from 
10 to 210 kHz during measurement. For measurements of MNPs associated with the cells, cells were incubated 
with MNPs for 72 h following which they were trypsinized. The trypsinized cells were resuspended in fresh media 
and transferred to the glass vial for AC susceptibility measurements. The cell samples had low levels of magnetic 
material which fell below the detection limits of AC susceptometer at the higher frequency range. Hence, meas-
urements for these samples were limited to < 10 kHz frequency. All susceptibility measurements were performed 
at 37 °C (310 K) to maintain physiological temperature.
For Brownian relaxation, the hydrodynamic radius rH, can be calculated using the frequency (fB) of the χ” 
peak, from equation (1) where VH is the hydrodynamic volume ( pi=V rH H
3
4
3 ), η the viscosity of the solvent (water, 
η = 1 × 10−3 Pa.s), k, the Boltzmann constant (k = 1.38 × 10−23 kgms−2 K−1) and T, the temperature (K). The fre-
quency limits of 10 Hz and 210 kHz mean that MNPs with hydrodynamic diameter between ~350 to ~13 nm can 
be detected when suspended in water at 37 °C (310 K).
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f
V
kT
1
2
3
(1)B
H
Microscopy. The live dead dual staining kit for mammalian cells (Life Technologies, UK) was used to assess 
cell viability. 2 μ M of Calcein-AM (CAM) in phosphate buffered saline (PBS) was added to stain live cells green 
and 4 μ M of the nuclear stain ethidium homodimer (EthD) in PBS was added to stain compromised cells red. 
Cells were incubated with the dyes at 25 °C in the dark for 30 min. Following this, excess stain was washed off 
and fresh media added. Cells were immediately imaged under bright field and fluorescent conditions in Olympus 
IX83 confocal microscope fitted with a camera using the Fluorview 10 software.
Flow cytometry quantification. For flow cytometry, cells were seeded in 24 well plates and tested similar 
to the fluorimetry samples. Staining was performed using 1 μ M CAM and 2 μ M EthD as these concentrations gave 
optimum levels of fluorescence in the cytometer. Incubation with the dyes was performed at 37 °C for 15 min. 
Incubation at higher temperatures caused the cells to lift off compared to incubation at room temperature and 
this helped obviate the trypsinization step during sample preparation circumventing any deleterious effect trypsin 
might have on cell viability. The cells were resuspended in round-bottom tubes, washed and resuspended in flow 
cytometry buffer (1% bovine serum albumin in PBS). Five to ten thousand events gated on size (forward scatter) 
and granularity (side scatter) were analysed. For flow cytometry, a separate set of controls were prepared for every 
set of samples. The controls included live cells without any staining, stained only for CAM, only for EthD and for 
both the dyes. Identical set of controls were prepared for compromised cells (cells treated with 70% methanol). 
The controls were used for setting the parameters and compensation values in the flow cytometer.
Flow cytometry was performed on a Becton Dickinson FC500 flow cytometer The CellQuestPro software 
(Becton Dickinson, UK) was used for data acquisition and the Cyflogic software (CyFlo Ltd.) for further data 
analysis. CAM fluorescence was measured using the FL1 gate in the flow cytometer while EthD fluorescence was 
measured in the FL3 region. Compensation for leakage of CAM into FL3 region was performed by matching the 
geometric mean of unstained cells’ fluorescence in FL3 to that of live cells stained for only CAM. Similar compen-
sation was performed for leakage of EthD fluorescence in the FL1 using unstained and compromised cells stained 
for EthD alone. 99% of the unstained cell population was set to fall under the live staining background using FL1 
histogram and similarly for the compromised staining background values. These setting were then used to filter 
the background fluorescence for the actual samples in FL1 vs. FL3 log plot.
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Osteogenic differentiation studies. Cells were seeded at 12,000 cells/well in 24 well plates and incubated 
with MNPs for 72 h. Following this, the unbound MNPs were washed off with PBS and expansion media or 
osteogenic media were added. Osteogenic differentiation media was prepared by adding 0.1 μ M Dexamethasone, 
10 mM β -glycerophosphate, 50 μ M ascorbic acid and 1% non-essential amino acids (all from Sigma- Aldrich, UK) 
to the expansion media. Media was replaced every 3 days once and at day 7 and 14, wells were washed with PBS 
and sterile water was added to wells. Cells were lysed by repeated freeze-thaw cycles. Lysates were used for both 
ALP and DNA assays. ALP was measured via the 4-Methylumbelliferyl phosphate (4-MUP) Liquid Substrate 
System (Sigma- Aldrich, UK). In brief, lysates were incubated with equal volume of 4-MUP reagent for 30 min in 
the dark at 37 °C. Following this, the fluorescence was measured in a plate reader (BioTek Instrument Inc.) at Ex/
Em of 360/440 nm. For normalizing to the number of cells, the double stranded DNA content was measured using 
the Quant-iT™ PicoGreen® dsDNA Assay Kit (Life Technologies, UK). Lysates were incubated with 1.5 times 
volume of the Picogreen reagent at room temperature in the dark for 15 min. After incubation, the fluorescence 
was read at Ex/Em of 485/535 nm.
Statistics. Each column in Figs 4 and 5 represent the mean (n = 3) and the error bars are the standard error 
of the mean. For flow cytometry (Fig. 4), experimental triplicates (n = 3) were assessed with each sample meas-
ured until 10,000 counts were obtained. In some samples with very low viability, due to insufficient cell numbers, 
the triplicates were combined to form a single sample and measured to obtain 10,000 counts. Hence for these 
samples, no error bars are shown in the columns and because of this it was not possible to perform a statistical 
comparison for significance in the data in this figure. For Fig. 5, one-way ANOVA was performed in conjunction 
with Tukey’s HSD test. The sample variance was confirmed to be equal between groups for ANOVA.
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